Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

Published:2019-05-22 Issue:7 Volume:98 Page:1781-1783
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Shimizu Ryo,Takeuchi Masahiro^ORCID,Sakaida Emiko,Ohwada Chikako,Toyosaki Masako,Machida Shinichiro,Onizuka Makoto,Shono Katsuhiro,Onoda Masahiro,Saito Takeshi,Yano Shingo,Tanaka Masatsugu,Fujisawa Shin,Mori Takehiko,Usuki Kensuke,Takahashi Satoshi,Kanamori Heiwa,Nakaseko Chiaki,Okamoto Shinichiro

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03717-8.pdf

Reference10 articles.

1. Aung FM, Lichtiger B, Bassett R, Liu P, Alousi A, Bashier Q, Ciurea SO, de Lima MJ, Hosing C, Kebriaei P, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Khouri I, Champlin RE, Popat U (2013) Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol 160(6):798–805. https://doi.org/10.1111/bjh.12210

2. Hirokawa M, Fukuda T, Ohashi K, Hidaka M, Ichinohe T, Iwato K, Kanamori H, Murata M, Sakura T, Imamura M, Adachi S, Suzuki R, Morishima Y, Sakamaki H, Group PCS (2013) Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors. Biol Blood Marrow Transplant 19(7):1026–1032. https://doi.org/10.1016/j.bbmt.2013.04.004

3. Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M (1990) Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75(1):290–295

4. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98(6):1687–1694

5. Olivieri NF (1999) The beta-thalassemias. N Engl J Med 341(2):99–109. https://doi.org/10.1056/NEJM199907083410207

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab;Transfusion;2024-02-13

2. Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-08

3. Pure red blood cell aplasia: patient management pitfalls in major ABO‐incompatible haematopoietic cell transplantation;British Journal of Haematology;2021-04-12

4. Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study;British Journal of Haematology;2021-04-12

5. Iron overload in the HCT patient: a review;Bone Marrow Transplantation;2021-03-29